These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36544831)

  • 21. Inadvertent intralenticular dexamethasone implant: 1-year follow-up and management.
    Caglar C
    Oman J Ophthalmol; 2017; 10(3):235-237. PubMed ID: 29118503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repositioning and follow-up of intralenticular dexamethasone implant.
    Munteanu M; Rosca C
    J Cataract Refract Surg; 2013 Aug; 39(8):1271-4. PubMed ID: 23889870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilizing dexamethasone intravitreal implant to control postoperative inflammation in refractory uveitis undergoing cataract surgery.
    Li YT; Cui XX; Yang XT; Li B; Ren XJ; Li XR; Zhang XM
    Int J Ophthalmol; 2021; 14(2):317-322. PubMed ID: 33614464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital].
    Bernard Y; Bonnin N; Farguette F; Chiambaretta F
    J Fr Ophtalmol; 2016 Jan; 39(1):1-4. PubMed ID: 26616298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accidental intralenticular injection of Ozurdex®.
    Zubicoa A; Andonegui J; Mozo Cuadrado M; Tabuenca Del Barrio L
    Arch Soc Esp Oftalmol (Engl Ed); 2020 Jan; 95(1):e1. PubMed ID: 31759731
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report.
    Pacella F; Agostinelli E; Carlesimo SC; Nebbioso M; Secondi R; Forastiere M; Pacella E
    J Med Case Rep; 2016 Oct; 10(1):282. PubMed ID: 27733187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intralenticular foreign body with a clear lens.
    Niazi MK; Arain MA; Khan MD; Dar AJ; Yaqub A; Adeeb L
    J Coll Physicians Surg Pak; 2010 Mar; 20(3):214-5. PubMed ID: 20392390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis.
    Hasanreisoğlu M; Özdemir HB; Özkan K; Yüksel M; Aktaş Z; Atalay HT; Özdek Ş; Gürelik G
    Turk J Ophthalmol; 2019 Oct; 49(5):250-257. PubMed ID: 31650791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical management of a traumatic intralenticular abscess: a case report.
    Sayadi J; Mekni M; Kallel Z; Choura R; Gouider D; Malek I; Nacef L
    Pan Afr Med J; 2022; 41():81. PubMed ID: 35432703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intralenticular Ozurdex implant: What to do and how.
    Valverde-Megías A; Hernández-Ruiz S; Cifuentes-Canorea P; Santos-Bueso E
    J Fr Ophtalmol; 2018 Apr; 41(4):e149-e150. PubMed ID: 29650259
    [No Abstract]   [Full Text] [Related]  

  • 31. Intralenticular metallic foreign body.
    Lee LR; Briner AM
    Aust N Z J Ophthalmol; 1996 Nov; 24(4):361-3. PubMed ID: 8985549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraoperative Dexamethasone Intravitreal Implant (Ozurdex) in Vitrectomy Surgery for Epiretinal Membrane.
    Hostovsky A; Muni RH; Eng KT; Mulhall D; Leung C; Kertes PJ
    Curr Eye Res; 2020 Jun; 45(6):737-741. PubMed ID: 31765241
    [No Abstract]   [Full Text] [Related]  

  • 33. ON THE ENZYMOLOGY OF THE REFRACTORY MEDIA OF THE EYE. VII. CHANGES IN TRANSPARENCY AND COMPOSITION OF RABBIT LENSES AFTER INTRALENTICULAR INJECTIONS OF IODOACETATE AND PAPAIN.
    SHOCK D; ZELLER EA
    Am J Ophthalmol; 1964 May; 57():737-41. PubMed ID: 14167181
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravitreal Bevacizumab for Inflammatory Neovascularization of the Lens after Traumatic Open Globe Injury.
    Hwang JH; Jeong KD; Chung KH; Park JH; Choi J; Oh WH; Kim JS
    Ocul Immunol Inflamm; 2020 May; 28(4):699-702. PubMed ID: 31268802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease].
    Brunner M; Haueter I; Valmaggia C
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):396-400. PubMed ID: 23629790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexamethasone intravitreal implant (OZURDEX
    Massa H; Georgoudis P; Panos GD
    Ther Deliv; 2019 Jun; 10(6):343-351. PubMed ID: 31184554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative cataract surgery use of an intravitreal dexamethasone implant (Ozurdex) in a patient with juvenile idiopathic arthritis and chronic anterior uveitis.
    Cordero-Coma M; Garzo I; Calleja S; Galán E; Franco M; Ruíz de Morales JG
    J AAPOS; 2013 Dec; 17(6):632-4. PubMed ID: 24215803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitreoretinal surgery for inadvertent intralenticular Ozurdex implant.
    Chalioulias K; Muqit MM
    Eye (Lond); 2014 Dec; 28(12):1523-4. PubMed ID: 25104743
    [No Abstract]   [Full Text] [Related]  

  • 39. Intralenticular implant study in pigmented rabbits: opacity lensmeter assessment.
    Gwon A; Kuszak J; Gruber LJ
    J Cataract Refract Surg; 1999 Feb; 25(2):268-77. PubMed ID: 9951676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors.
    Tservakis I; Koutsandrea C; Papaconstantinou D; Paraskevopoulos T; Georgalas I
    Curr Drug Saf; 2015; 10(2):145-51. PubMed ID: 25092480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.